Modular Assembly of Interdigitated Osteochondral Interfaces
Modular Assembly of Interdigitated Osteochondral Interfaces
批准号:
8640078
负责人:
JAN P. STEGEMANN
金额:
$15.46万
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-05-01 至 2016-04-30
关键词:
AddressAdultArchitectureAutologousBiochemicalCaliberCartilageCell DeathCell TransplantationCellsChitosanChondrocytesClinicalClinical TreatmentCollagenComplexDefectEncapsulatedEvaluationExploratory/Developmental GrantExtracellular MatrixFailureFibrocartilagesGeometryGoalsHealedHistocompatibility TestingHumanHydrogelsHydroxyapatitesLeadMechanicsMesenchymal Stem CellsMethodsMicrospheresNatural regenerationNatureOrthopedicsOutcomePhasePhenotypePopulationProceduresResolutionSolutionsStem cellsStructureTestingTherapeuticThickTimeTissue EngineeringTissue TransplantationTissuesTransplantationTransplanted tissueVariantbasebonebone engineeringcartilage repairdesigndesign and constructionhealingimprovedinnovationinsightinterfacialnew technologynext generationnovel strategiesosteochondral tissueosteogenicpublic health relevancerepairedresearch and development
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Large, full thickness cartilage defects typically require cell or tissue transplantation to promote regeneration, however current clinical treatments are hampered by a lack of tissue availability and inadequate integration of the transplanted tissue. Tissue engineering offers a solution by creating osteochondral tissues that could be used for transplantation. However, achieving tight integration between engineered bone and cartilage tissues is challenging. The objective of this two-year exploratory project is to address this problem by creating continuous, strong osteochondral interfaces using a modular tissue engineering approach. Discrete microbeads (200-50 in diameter) made from extracellular matrix materials (collagen, chitosan, hydroxyapatite) will be used to encapsulate and control the phenotype of adult human mesenchymal stem cells (hMSC). Osteogenic and chondrogenic populations of microbeads will be created separately and then combined to form cohesive multiphase tissue constructs. Control of the assembly of the component microbeads provides a way to prescribe the organization of the resulting interface. The general hypothesis upon which this project is based is that the architecture of the interface between chondrogenic and osteogenic microbeads can be manipulated to promote integration of these two tissue types, thereby leading to strong and stable osteochondral tissues. This project addresses three specific sub-hypothesis that provide insight into the effects of geometry, scale, and timing of formation of osteochondral interfaces. These hypotheses will be tested through two Specific Aims. In SA1 we will create osteochondral tissues and interfaces by combining chondrogenic and osteogenic microbeads in both layered and continuous architectures. In parallel, SA2 will comprehensively characterize the microbeads and osteochondral constructs at selected time points, with particular emphasis on interfacial organization and strength through biochemical, histological and mechanical assessment. By creating 3D multiphase constructs using the hydrogel microbead approach we expect to achieve enhanced integration of engineered bone and cartilage tissue. The ability to design robust and highly interconnected bone-cartilage constructs could lead to improved treatment of osteochondral defects.
期刊论文(7)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1016/j.jcyt.2015.10.015
发表时间:
2016-02
期刊:
Cytotherapy
影响因子:
4.5
作者:
[Tiruvannamalai Annamalai R, Mertz DR, Daley EL, Stegemann JP]
通讯作者:
Stegemann JP
DOI:
10.1002/adhm.201200346
发表时间:
2013-05
期刊:
ADVANCED HEALTHCARE MATERIALS
影响因子:
10
作者:
[Caldwell, David J., Rao, Rameshwar R., Stegemann, Jan P.]
通讯作者:
Stegemann, Jan P.
Cell therapy for bone repair: narrowing the gap between vision and practice.
骨修复细胞疗法:缩小愿景与实践之间的差距。
DOI:
10.22203/ecm.v027sa01
发表时间:
2014
期刊:
European cells & materials
影响因子:
3.1
作者:
[Stegemann,JP, Verrier,S, Gebhard,F, Laschke,MW, Martin,I, Simpson,H, Miclau,T]
通讯作者:
Miclau,T
DOI:
10.1016/j.actbio.2013.08.038
发表时间:
2014-04
期刊:
ACTA BIOMATERIALIA
影响因子:
9.7
作者:
[Walters, B. D., Stegemann, J. P.]
通讯作者:
Stegemann, J. P.
DOI:
10.3109/03008207.2015.1072519
发表时间:
2016-11
期刊:
Connective tissue research
影响因子:
2.9
作者:
[Wise JK, Alford AI, Goldstein SA, Stegemann JP]
通讯作者:
Stegemann JP
Clincial Immersion and Experiential Learning in Medical Product Innovation
-
批准号:8848576
-
项目类别:
-
资助金额:$3.3万
-
财政年份:2015
-
负责人:JAN P. STEGEMANN
-
依托单位:
Bone Regeneration Using Osteogenic and Vasculogenic Tissue Modules
-
批准号:9295974
-
项目类别:
-
资助金额:$34.1万
-
财政年份:2014
-
负责人:JAN P. STEGEMANN
-
依托单位:
Bone Regeneration Using Osteogenic and Vasculogenic Tissue Modules
-
批准号:9088366
-
项目类别:
-
资助金额:$32.93万
-
财政年份:2014
-
负责人:JAN P. STEGEMANN
-
依托单位:
Bone Regeneration Using Osteogenic and Vasculogenic Tissue Modules
-
批准号:8816857
-
项目类别:
-
资助金额:$33.14万
-
财政年份:2014
-
负责人:JAN P. STEGEMANN
-
依托单位:
Modular Assembly of Interdigitated Osteochondral Interfaces
-
批准号:8512268
-
项目类别:
-
资助金额:$18.81万
-
财政年份:2013
-
负责人:JAN P. STEGEMANN
-
依托单位:
Directed Differentiation of Human Mesenchymal Stem Cells for Bone Repair
-
批准号:7144909
-
项目类别:
-
资助金额:$32.21万
-
财政年份:2006
-
负责人:JAN P. STEGEMANN
-
依托单位:
Directed Differentiation of Human Mesenchymal Stem Cells for Bone Repair
-
批准号:7477826
-
项目类别:
-
资助金额:$32.48万
-
财政年份:2006
-
负责人:JAN P. STEGEMANN
-
依托单位:
Directed Differentiation of Human Mesenchymal Stem Cells for Bone Repair
-
批准号:7271371
-
项目类别:
-
资助金额:$31.91万
-
财政年份:2006
-
负责人:JAN P. STEGEMANN
-
依托单位:
Directed Differentiation of Human Mesenchymal Stem Cells for Bone Repair
-
批准号:7669341
-
项目类别:
-
资助金额:$30.49万
-
财政年份:2006
-
负责人:JAN P. STEGEMANN
-
依托单位:
Composite Scaffolds for Vascular Tissue Engineering
-
批准号:6915572
-
项目类别:
-
资助金额:$17.33万
-
财政年份:2004
-
负责人:JAN P. STEGEMANN
-
依托单位:
Composite Scaffolds for Vascular Tissue Engineering
-
批准号:6808794
-
项目类别:
-
资助金额:$19.97万
-
财政年份:2004
-
负责人:JAN P. STEGEMANN
-
依托单位:
海外基金